A hypothetical case of nasal microbiome transplantation

Similar documents
Responders as percent of overall members in each category: Practice: Adult 490 (49% of 1009 members) 57 (54% of 106 members)

Success for a MRSA Reduction Program: Role of Surveillance and Testing

Prevalence & Risk Factors For MRSA. For Vets

Sixth Plague of Egypt. Community MRSA. Epidemiology. Basic Features of Community MRSA. Populations with CA-MRSA

Community Methicillin- Resistant Staphylococcus aureus. Sixth Plague of Egypt. Epidemiology

HOSPITAL-ACQUIRED INFECTION/MRSA EYERUSALEM KIFLE AND GIFT IMUETINYAN OMOBOGBE PNURSS15

Replaces:04/14/16. Formulated: 1997 SKIN AND SOFT TISSUE INFECTION

A patient s guide to. MRSA - Methicillin Resistant Staphylococcus Aureus

Is biocide resistance already a clinical problem?

Case: Family D. Staphylococcus aureus. Outline. Staphylococcus aureus Timeline. Newborn Nursery Epidemic: 1950s

Risk factors? Insect bites? Hygiene? Household crowding Health literacy

Methicillin Resistant Staphylococcus Aureus (MRSA) The drug resistant `Superbug that won t die

Multi-Drug Resistant Organisms (MDRO)

Evaluating the Role of MRSA Nasal Swabs

MRSA Background. New Challenges From an Old Foe. MRSA Demographics. Comparison of Types of MRSA CA-MRSA HA-MRSA

Methicillin Resistant Staphylococcus aureus:

PVL Staph aureusjust a skin/soft tissue problem? Layla Mohammadi Lead Pharmacist, Antimicrobials Lewisham Healthcare NHS Trust

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections Activity C: ELC Prevention Collaboratives

Preventing Multi-Drug Resistant Organism (MDRO) Infections. For National Patient Safety Goal

GUIDE TO INFECTION CONTROL IN THE HOSPITAL

Hosted by Dr. Jon Otter, Guys & St. Thomas Hospital, King s College, London A Webber Training Teleclass 1

Staphylococcus Aureus

THE HUMAN MICROBIOME: THE INFECTION PREVENTIONIST S BEST FRIEND

Source: Portland State University Population Research Center (

MRSA What We Need to Know Sharon Pearce, CRNA, MSN Carolina Anesthesia Associates

Opening the Gates for Farmer Health National Center for Farm Health October 13, 2010

Today s Agenda: 9/30/14

Preventing Surgical Site Infections. Edward L. Goodman, MD September 16, 2013

M R S A. Methicillin-Resistant Staphylococcus aureus. The Facts

Lindsay E. Nicolle University of Manitoba Winnipeg, CANADA

Development of Drugs for Eradication of Nasal Carriage of S. aureus to Reduce S. aureus Infections in Vulnerable Surgical Patients

Can you treat mrsa with amoxicillin

Antibiotic stewardship in long term care

Standing Orders for the Treatment of Outpatient Peritonitis

Surveillance of Multi-Drug Resistant Organisms

Horizontal vs Vertical Infection Control Strategies

FM - Male, 38YO. MRSA nasal swab (+) Due to positive MRSA nasal swab test, patient will be continued on Vancomycin 1500mg IV q12 for MRSA treatment...

Methicillin-Resistant Staphylococcus aureus

Standing Orders for the Treatment of Outpatient Peritonitis

A Prospective Investigation of Nasal Mupirocin, Hexachlorophene Body Wash, and Systemic

Active Bacterial Core Surveillance Site and Epidemiologic Classification, United States, 2005a. Copyright restrictions may apply.

Impact of a Standardized Protocol to Address Outbreak of Methicillin-resistant

Healthcare-associated Infections Annual Report December 2018

Keeping Antibiotics Working: Nursing Leadership in Action

MRSA Screening (Elective Patients)

Approval Signature: Original signed by Dr. Michel Tetreault Date of Approval: July Review Date: July 2017

Joint scientific report of ECDC, EFSA and EMEA on meticillin resistant Staphylococcus aureus (MRSA) in livestock, companion animals and food 1.

A LONGITUDINAL STUDY OF COMMUNITY-ASSOCIATED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS COLONIZATION IN COLLEGE SPORTS PARTICIPANTS

In-Service Training Program. Managing Drug-Resistant Organisms in Long-Term Care

Principles of Antimicrobial Therapy

Your Guide to Managing. Multi Drug-resistant Organisms (MDROs)

Treatment of Surgical Site Infection Meeting Quality Statement 6. Prof Peter Wilson University College London Hospitals

Multi-drug resistant microorganisms

MRSA Outbreak in Firefighters

Multidrug-Resistant Organisms: How Do We Define them? How do We Stop Them?

Mrsa abscess and cellulitis

Does Screening for MRSA Colonization Have A Role In Healthcare-Associated Infection Prevention Programs?

Hand washing/hand hygiene reduces the number of microorganisms on the hands and is the most important practice to prevent the spread of infection.

8/17/2016 ABOUT US REDUCTION OF CLOSTRIDIUM DIFFICILE THROUGH THE USE OF AN ANTIMICROBIAL STEWARDSHIP PROGRAM

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

THE BOVINE MILK MICROBIOME. Mark McGuire

CONFLICT OF INTEREST ANTIMICROBIAL LOCK SOLUTIONS INCREASE BACTEREMIA

Antimicrobial Resistance and Molecular Epidemiology of Staphylococcus aureus in Ghana

LA-MRSA in the Netherlands: the past, presence and future.

Infection Prevention Highlights for the Medical Staff. Pamela Rohrbach MSN, RN, CIC Director of Infection Prevention

Community-Associated Methicillin-Resistant Staphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic

Community Associated MRSA Dr. Rachel Gorwitz, CDC A Webber Training Teleclass

Ca-MRSA Update- Hand Infections. Washington Hand Society September 19, 2007

Impact of Systemic Antibiotics on Staphylococcus aureus Colonization and Recurrent Skin Infection

The Bug Stops Here: Treating Resistant Staph Infections Holly Roberts, DVM, MS, DACVD Blue Pearl Veterinary Specialists San Antonio, TX

original article infection control and hospital epidemiology october 2009, vol. 30, no. 10

MRSA: How to Keep This Deadly Super Bug From Infecting You

Infection Control Priorities for Antibiotics Resistance - The Search and Destroy Strategy. WH Seto Hong Kong China

Epidemiology of Community- Associated (CA) Methicillin-Resistant Staphylococcus aureus (MRSA) in the United States

Health Service Executive Parkgate St. Business Centre, Dublin 8 Tel:

Author - Dr. Josie Traub-Dargatz

Isolation of MRSA from the Oral Cavity of Companion Dogs

Overview of Infection Control and Prevention

NHS GRAMPIAN MRSA POLICY FOR COMMUNITY SETTINGS JUNE 2003

Healthcare-associated infections surveillance report

Staph Cases. Case #1

Staphylococcus aureus Blood Stream Infection (Bacteraemia) Surveillance. Ceredigion and Mid Wales Trust Data per Bed Days

22/10/2013. antibiotic resistance an ecological problem. this part of the session. an ecological perspective. selection pressure and evolution

Get Smart For Healthcare

Living with MRSA Learning how to control the spread of Methicillin-Resistant Staphylococcus Aureus (MRSA)

A Randomized, Double-Blinded Study for the Prevention of Exit Site Infections in Pediatric Peritoneal Dialysis Patients

Skin & Soft Tissue Infections (SSTI) Skin & Soft Tissue Infections. Skin & Soft Tissue Infections (SSTI)

Conflict of interest: We have no conflict of interest to report on this topic of SSI reduction for total knees.

Nasal Antisepsis Methods: Povidone-Iodine vs Alcohol Based Solutions

What Is Thought To Be The Problem?

ON-DEMAND. Converging pressures encourage rapid MRSA/SA testing

Antibiotics & Emerging Resistance

Other Enterobacteriaceae

Screening for MRSA / MSSA and CPO within the Kent Kidney Care Centre

Research Article Evaluation of Central Venous Catheter Associated Blood Stream Infections: A Microbiological Observational Study

Meropenem for all? Midge Asogan ICU Fellow (also ID AT)

11/10/2016. Skin and Soft Tissue Infections. Disclosures. Educational Need/Practice Gap. Objectives. Case #1

Taking Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home: Part 2 Understanding the spread

Wound Management. Elof Eriksson MD PhD Professor Emeritus, Harvard Medical School Chief Medical Officer, Applied Tissue Technologies LLC

Transcription:

A hypothetical case of nasal microbiome transplantation Katherine P. Lemon, MD, PhD Institute & Boston Children s Hospital Mary-Claire Roghmann, MD, MS University of Maryland Microbiota-transplantation Working Group December 12, 2016

The Problem: repeated Staphylococcus aureus infections Child with a complex medical condition Dependent on a central venous catheter S. aureus (MSSA) brain abscess Later a S. aureus (MSSA) bacteremia S. aureus nasal & skin decolonization failed A third S. aureus (MSSA) infection

What next? Risk for repeat S. aureus infections Repeat decolonization, which might fail There is no vaccine against S. aureus

Staphylococcus aureus colonizes the human nose, skin and throat nostrils throat segments back of nose back of mouth lower throat Wertheim LID 2005 (rev) Mertz CID 2007

Staphylococcus aureus lives in the noses of ~25% of humans Colonization increases the risk of infection Gorwitz JID 2008

Most Staphylococcus aureus interactions with humans are harmless Harmless Infection

Staphylococcus aureus also causes infection Harmless Infection

Staphylococcus aureus kills up to 10,000 people per year in the U.S. CDC. Active Bacterial Core Surveillance Report, 2005-2011

S. aureus causes a range of infections Skin & soft tissue Bone Joint Blood stream Heart valve Pneumonia Medical devices

Some people experience repeated S. aureus infections USA300 clone of MRSA Reports of multiple recurrences Reports of multiple MRSA infections, e.g., SSTIs, within a household

Why are 75% of people are free of Staphylococcus aureus? and have a lower risk of infection

Our genetics has little influence on whether Staphylococcus aureus lives in our nose Andersen et al. JID 2012

other bacteria in the nose likely do Liu et al. Sci Adv 2015

Studies have identified bacterial genera/species inversely correlated with S. aureus Frank et al. PONE 2010 Wos-Oxley et al. ISME J 2010 Yan et al. CHM 2013

Can other members of the nasal microbiome keep S. aureus out? Benign or beneficial S. aureus

The Problem: repeated Staphylococcus aureus infections Child with a complex medical condition Dependent on a central venous catheter S. aureus (MSSA) brain abscess Later a S. aureus (MSSA) bacteremia S. aureus nasal & skin decolonization failed A third S. aureus (MSSA) infection

Hypothesis: the nasal microbiome can be replaced by one resistant to S. aureus Repeat decolonization to perturb the ecosystem Community will repopulate secondary succession Guide repopulation: Nasal Microbiota Transplant Donor: long-term S. aureus non-carrier Goal: to prevent S. aureus infection by eradicating S. aureus colonization

S. aureus nasal and skin decolonization First 5 days of every month for 3-4 cycles Topical antibiotic to both nostrils twice daily mupirocin Topical microbicide wash/bath once daily Chlorhexidine Dilute bleach Decolonize the household (all S. aureus carriers) Limit sharing of S. aureus via household surfaces (e.g., avoid sharing towels) e.g., Fritz et al. CID 2012

Risks of S. aureus decolonization Generally well tolerated Localized reaction to the topic mupirocin or microbicide Potential to select for resistant S. aureus Mupirocin resistance The protocol may fail

Theoretical Nasal Microbiota Transplant Harvest microbiota with nostril swab(s) Donor: healthy and repeatedly negative for S. aureus colonization for >1 year Nostril, throat, axilla, inguinal fold and maybe GI Swab the nostrils of the recipient immediately after decolonization protocol Topical decolonization only? Oral antibiotics included in the decolonization? What about other carriers in the household? How long to monitor for recurrence/reacquisition of S. aureus?

The Lemon Lab at Developing new and sustainable ways to manage the bacterial microbiome in the nose and on the skin to prevent and treat infections. Boston Children s Hospital

Discussion

Why study bacteria that live in noses?

Bacterial interactions with humans range from beneficial to harmless to infection Beneficial Infection (pathogen)

We think about nasal bacteria in terms of how they affect humans Commensal Harmless Mutualist Beneficial Pathobiont Can cause severe disease

What keeps Staphylococcus aureus behaving harmlessly? Harmless Infection

A systems level view of a complex microbial community (microbiota)

Goal: identify molecular mechanisms that drive community composition/function Metabolites or Signals Antagonism Synergy